Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.

Yu-Ming HuLi-Hua ZhaoXiu-Lin ZhangHong-Li CaiHai-Yan HuangFeng XuTong ChenXue-Qin WangAi-Song GuoJian-An LiJian-Bin Su

Published in: Endocrine (2018)

In addition to conventional risks including diabetic duration, HOMA-IR and HbA1c, increased glycaemic variability assessed by MAGE is a significant independent contributor to DPN in type 2 diabetic patients.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
wound healing
peritoneal dialysis
human health
climate change